Science Explorer Back to mapMap
Discussion
Researcher · University of Cologne · Germany

Klaus Rajewsky

Klaus Rajewsky publishes mostly in Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as T-cell and B-cell Immunology, Immune Cell Function and Interaction and Monoclonal and Polyclonal Antibodies Research.

ORCID 0000-0002-6633-6370 OpenAlex
World rank
#8,153
of 7,710,434 ranked researchers
Rank in Germany
#348
of 364,343
Works
651
Citations
97k
Citations per work
149.7
h-index
157
i10-index 476Top 0.1% in Immunology
Klaus Rajewsky

What does Klaus Rajewsky research?

Klaus Rajewsky's work is mostly in Immunology and Microbiology (38%), Medicine (23%), Biochemistry, Genetics and Molecular Biology (22%).

Life Sciences: 392 works · 60.2% of their workImmunology and Microbiology: 249 works · 38.2% of their workImmunology: 249 works · 38.2% of their workBiochemistry, Genetics and Molecular Biology: 143 works · 22.0% of their workMolecular Biology: 115 works · 17.7% of their workCancer Research: 28 works · 4.3% of their workHealth Sciences: 148 works · 22.7% of their workMedicine: 148 works · 22.7% of their workRadiology, Nuclear Medicine and Imaging: 76 works · 11.6% of their workOncology: 43 works · 6.6% of their workPathology and Forensic Medicine: 29 works · 4.5% of their workEverything else: 111 works · 17.1% of their workTHEIR WORKKlaus Rajewsky651works
Life Sciences60%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology24938.2%
    2. Biochemistry, Genetics and Molecular Biology14322.0%
    1. Medicine14822.7%
  3. Everything else11117.1%
  1. 1Immunology38% of their works
  2. 2Molecular Biology18% of their works
  3. 3Radiology, Nuclear Medicine and Imaging12% of their works
  4. 4Oncology7% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Klaus Rajewsky's research?

The keywords of their largest research topics: Foxp3, TGF-ß, Glycosylation, Natural Killer Cells, NK Cell Recognition, Fc Receptors, Therapeutic Antibodies and Lymphoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Foxp32771 topic
  2. TGF-ß2771 topic
  3. Glycosylation2512 topics
  4. NK Cell Recognition2131 topic
  5. Natural Killer Cells2131 topic
  6. Fc Receptors1981 topic
  7. Therapeutic Antibodies1981 topic
  8. Lymphoma1252 topics
  9. Cancer Immunotherapy1182 topics
  10. Rituximab1162 topics
  11. Classification721 topic
  12. Molecular Profiling721 topic
  13. Dendritic Cells651 topic
  14. Immunity651 topic
  15. CAR T Cells531 topic
  16. Cancer531 topic
  17. Chimeric Antigen Receptor531 topic
  18. Glycans531 topic
  19. Chronic Lymphocytic Leukemia441 topic
  20. Genomic Aberrations441 topic

Where does Klaus Rajewsky work?

Klaus Rajewsky's main affiliation in the publication record is University of Cologne, Germany.

How many publications and citations does Klaus Rajewsky have?

OpenAlex counts 651 works and 97,461 citations for Klaus Rajewsky, an h-index of 157, ranking #8,153 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Klaus Rajewsky. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.